Boston, USA-based contract research organization (CRO) Novotech has made two new appointments to its senior executive team.
The firm has hired Rick Farris as managing director for North America, while David Ng has taken on the position of global vice president for biometrics and data management.
Chief executive John Moller said: “Rick's extensive background, with 22 years in biotech clinical research and drug development, complemented by over 30 years in the life sciences, makes him exceptionally qualified for this critical leadership role within our North American operations.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze